Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-04

Clinical Trial Update: LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences [NA]

View source ↗

Summary

A clinical trial update announcing a not-yet-recruiting study evaluating LCMD for Type 2 diabetes remission and exploring individual differences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LCMD

Snippet

Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine | Conditions: Type 2 Diabetes Mellitus in Obese, Type 2 Diabetes | NA | Status: NOT_YET_RECRUITING